Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
S
Shivangi Shrimali
Researcher
Also affiliated: United States Food and Drug Administration (2025–2026)
Unknown Researcher
3 h-index
6 pubs
32 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shivangi Shrimali's research focuses on developing and evaluating new methodologies for drug safety assessment, particularly in the context of drug-induced liver injury (DILI) and radioprotection. Her work investigates the use of microphysiological systems, also known as new approach methodologies (NAMs), as alternatives to traditional animal testing for evaluating drug absorption, distribution, metabolism, excretion, and toxicity. Shrimali has also explored the potential of tocotrienol analogues, such as tocoflexol, as radioprotective agents, examining their antioxidant and signaling mechanisms. Her research also includes investigating the effects of specific substances, like titanium dioxide, on cellular processes, such as microRNA expression. Shrimali collaborates with researchers from the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Metrics
- h-index: 3
- Publications: 6
- Citations: 32
Selected Publications
-
Integrating in vitro and in silico NAMs for enhanced prediction of drug-induced liver injury (2026)
-
Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells (2026)
-
Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity (2025)
-
New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? (2025)
-
Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects (2023)
-
466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator (2023)
Collaboration Network
Top Collaborators
Shraddha Thakkar
University of Arkansas for Medical Sciences (US)
2 shared publications
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Darin E. Jones
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Nükhet Aykin‐Burns
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Philip J. Breen
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
César M. Compadre
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Dongying Li
2 shared publications
In database
- New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
- Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity
Weida Tong
National Center for Toxicological Research
2 shared publications
In database
- New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
- Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity
Awantika Singh
University of Arkansas for Medical Sciences (US)
1 shared publication
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Rajeshkumar Manian
1 shared publication
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Stephen Shrum
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Ujwani Nukala
University of Arkansas at Little Rock (US)
1 shared publication
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Edith Nathalie Pineda
University of Arkansas at Little Rock
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Kimberly J. Krager
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Rupak Pathak
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Minjun Chen
National Center for Toxicological Research
1 shared publication
In database
- New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
Similar Researchers
Based on overlapping research topics
Katy S Papineau
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Disease Models, Animal
Ji‐Eun Seo
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Disease Models, Animal
Lawrence Grylack
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Molecular Biology Techniques and Applications
S A Montoya Guerrero
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Disease Models, Animal
Molecular Biology Techniques and Applications
Madison Blue
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Molecular Biology Techniques and Applications
Jessica Hawes Oliphant
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Disease Models, Animal